{"id":"NCT00457626","sponsor":"Novartis Pharmaceuticals","briefTitle":"A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension","officialTitle":"An Open Label Extension Study to Evaluate Safety, Tolerability, and Efficacy of 18 Weeks of Valsartan Treatment in Children 6 Months-5 Years Old With Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-04-09","primaryCompletion":"2009-05-25","completion":"2009-05-25","firstPosted":"2007-04-06","resultsPosted":"2021-05-20","lastUpdate":"2021-09-05"},"enrollment":66,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Valsartan","otherNames":[]}],"arms":[{"label":"Valsartan Open Label","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy, safety and tolerability of long-term use (up to 18 weeks) of valsartan in children 6 months to 5 years old with hypertension.","primaryOutcome":{"measure":"Change From Baseline in Mean Sitting Systolic Blood Pressure (MSSBP)","timeFrame":"Baseline to Week 26","effectByArm":[{"arm":"Valsartan Open Label","deltaMin":114.7,"sd":9.04}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":36,"countries":["United States","Belgium","Brazil","France","Hungary","India","Italy","Poland","South Africa","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["23511339"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":66},"commonTop":["Pyrexia","Nasopharyngitis","Bronchitis","Upper respiratory tract infection","Viral infection"]}}